Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysis

Published on Aug 4, 2011in BMC Cancer3.15
· DOI :10.1186/1471-2407-11-336
Pavlos Msaouel24
Estimated H-index: 24
(Albert Einstein College of Medicine),
Pavlos Msaouel27
Estimated H-index: 27
(Albert Einstein College of Medicine)
+ -1 AuthorsMichael Koutsilieris60
Estimated H-index: 60
(UoA: National and Kapodistrian University of Athens)
Sources
Abstract
Background The diagnostic value and prognostic significance of circulating tumor cell (CTC) detection in patients with bladder cancer is controversial. We performed a meta-analysis to consolidate current evidence regarding the use of CTC detection assays to diagnose bladder and other urothelial cancers and the association of CTC positivity with advanced, remote disease.
📖 Papers frequently viewed together
20114.81BJUI
10 Authors (Michael Rink, ..., Sabine Riethdorf)
84 Citations
74 Citations
70 Citations
References62
Newest
#1Thomas J. Guzzo (Johns Hopkins University)H-Index: 32
#2Brian K. McNeil (Johns Hopkins University)H-Index: 8
Last. Mark P. Schoenberg (Johns Hopkins University)H-Index: 66
view all 6 authors...
Abstract Objective Due to imprecise clinical staging, the finding of extravesical and node-positive disease at the time of radical cystectomy (RC) for patients with clinically localized bladder cancer is not uncommon. Circulating tumor cells (CTCs) have been shown to be present in the peripheral blood of patients with metastatic urothelial carcinoma. The object of this study was to evaluate the ability of CTCs to predict extravesical disease in bladder cancer patients prior to RC. Materials and ...
42 CitationsSource
#1Andrianos Nezos (UoA: National and Kapodistrian University of Athens)H-Index: 5
#2Pavlos Msaouel (UoA: National and Kapodistrian University of Athens)H-Index: 27
Last. Michael Koutsilieris (UoA: National and Kapodistrian University of Athens)H-Index: 60
view all 10 authors...
Summary Disease dissemination is the major cause of melanoma-related death. A crucial step in the metastatic process is the intravascular invasion and circulation of melanoma cells in the bloodstream with subsequent development of distant micrometastases that is initially clinically undetectable and will eventually progress into clinically apparent metastasis. Therefore, the use of molecular methods to detect circulating melanoma cells may be of value in risk stratification and clinical manageme...
22 CitationsSource
#1Michael RinkH-Index: 27
#2Felix K.-H. ChunH-Index: 69
Last. Sabine RiethdorfH-Index: 66
view all 10 authors...
What’s known on the subject? and What does the study add? Circulating tumour cells (CTC) have prognostic relevance for patients with different metastatic carcinomas. Detection of CTC using the CellSearch system has also been reported in bladder cancer, but mainly in patients with metastatic disease. This is the largest report demonstrating that detection of CTC in non-metastatic bladder cancer patients is feasible using the CellSearch system. Presence of CTC may be predictive for early systemic ...
84 CitationsSource
#1Liang Cheng (IU: Indiana University)H-Index: 132
#2Shaobo Zhang (IU: Indiana University)H-Index: 57
Last. Rodolfo Montironi (United Hospitals)H-Index: 96
view all 6 authors...
Summary Transitional cell (urothelial) carcinoma of the bladder is the second most common urologic malignancy and is one of the best understood neoplasms, with relatively well-defined pathogenetic pathways, natural history, and tumor biology. Conventional clinical and pathologic parameters are widely used to grade and stage tumors and to predict clinical outcome of transitional cell carcinoma; but the predictive ability of these parameters is limited, and there is a lack of indices that could al...
149 CitationsSource
#1Shu Zhao (HMU: Harbin Medical University)H-Index: 19
#2Yupeng Liu (HMU: Harbin Medical University)H-Index: 4
Last. Maopeng Yang (HMU: Harbin Medical University)H-Index: 7
view all 9 authors...
The prognostic significance of circulating tumor cells (CTCs) in patients with breast cancer is controversial. We performed a meta-analysis of published literature to assess whether the detection of CTCs in patients diagnosed with primary breast cancer can be used as a prognostic factor. We searched Medline, Science Citation Index, and Embase databases as well as reference lists of relevant articles (including review articles) for studies that assessed the prognostic relevance of tumor cell dete...
56 CitationsSource
#1Javier C. AnguloH-Index: 41
#2A. FerrueloH-Index: 6
Last. Javier GonzálezH-Index: 7
view all 6 authors...
Abstract Introduction Molecular staging of bladder cancer based on the detection of mRNA of urothelial specific genes in circulating cancer cells has been inconclusive. We analyze whether real-time RT-PCR evaluation of gelatinases (MMP-9, MMP-2) and TIMP-2 in peripheral blood allows diagnosing and characterizing patients with bladder neoplasm. Materials and method Total RNA is extracted from circulating blood cells in 42 individuals (11 healthy controls, 31 patients with bladder cancer in differ...
12 CitationsSource
4 CitationsSource
#1Ahmedin Jemal (ACS: American Cancer Society)H-Index: 139
#2Rebecca L. Siegel (ACS: American Cancer Society)H-Index: 67
Last. Elizabeth Ward (ACS: American Cancer Society)H-Index: 18
view all 4 authors...
Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data regarding cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics. Incidence and death rates are age-...
11.2k CitationsSource
#1Angela GradiloneH-Index: 29
#2Arianna PetraccaH-Index: 7
Last. Paola GazzanigaH-Index: 29
view all 12 authors...
OBJECTIVE To evaluate the prognostic significance of survivin in tumour tissues and that of survivin-expressing circulating tumour cells (CTCs) in T1G3 bladder tumours, as the prognosis of T1G3 bladder cancer is highly variable and unpredictable from clinical and pathological prognostic factors. PATIENTS AND METHODS The study included 54 patients with T1G3 non-muscle-invasive bladder cancer. Additional inclusion criteria were: tumour size <3 cm, absence of carcinoma in situ and multifocality. Th...
42 CitationsSource
#1Takatsugu Okegawa (Kyorin University)H-Index: 25
#2Kenjiro Hayashi (Kyorin University)H-Index: 3
Last. Eiji Higashihara (Kyorin University)H-Index: 31
view all 5 authors...
Objectives: To evaluate the relationship between circulating tumor cells (CTC) and clinical parameters in metastatic urothelial cancer (UC). Methods: CTC were enumerated with the CellSearch System, which was developed using an EpCAM antibody-based immunomagnetic capture and automated staining methodology. UC cell lines (RT4, T24, TCC, UMUC3 and 253J) and mixed blood from healthy males were analyzed. Blood samples from 16 patients without metastatic UC and 20 patients with metastatic UC were also...
30 CitationsSource
Cited By54
Newest
#1Pei-Jhang Chiang (NDMC: National Defense Medical Center)
#2Ting Xu (NDMC: National Defense Medical Center)
Last. Chin-Li Chen (NDMC: National Defense Medical Center)H-Index: 6
view all 14 authors...
Programmed cell death ligand 1 (PD-L1) inhibitors are commonly used in treating advanced-stage urothelial carcinoma (UC). Therefore, this study evaluated the relationship between PD-L1 expression in circulating tumor cells (CTCs) and treatment response to PD-L1 inhibitors using blood samples collected from patients with UC (n = 23). Subsequently, PD-L1 expression and its clinical correlation were analyzed. All patients had CTCs before PD-L1 inhibitory treatment, of which 15 had PD-L1-positive CT...
Source
Background Circulating tumor cells (CTCs) have been considered diagnostic and prognostic biomarkers for urothelial cancer. However, the prognostic role of CTCs in bladder cancer (BC) remains controversial. Here, we conducted a meta-analysis to evaluate the prognostic significance of CTCs for patients with BC. null null Methods All studies relevant to this topic were searched in the PubMed, Embase, and Web of Science databases. The hazard ratio (HR) and 95% confidence interval (95% CI) were set a...
Source
(1) Background: Resistance mechanisms represent a barrier to anti-cancer therapies. Liquid biopsies would allow obtaining additional information in order to develop targeted therapies to thwart the resistance phenomena but also to follow in time real response to treatment and be able to adapt it the most quickly possible way in case of resistance. (2) Methods: herein we summarize the different liquid biopsies which are currently under research; we then review the literature and focalize on one o...
Source
Background Circulating tumor cells (CTCs) are cells that have been shed into the vasculature from a primary tumor and circulate in the bloodstream. It has been suggested that detecting CTCs could help the clinician to detect early metastasis or recurrence more effectively. This trial sets out to assess the detection and clinical value of CTCs as an assisted prognostic marker in patients with colon cancer and rectal cancer. Methods A prospective cohort of patients with colorectal cancer (CRC) was...
Source
#1Bartosz Małkiewicz (Wrocław Medical University)H-Index: 11
#2Paweł Kiełb (Wrocław Medical University)H-Index: 2
Last. Romuald Zdrojowy (Wrocław Medical University)H-Index: 14
view all 7 authors...
The purpose of this review is to present the current status of lymph node dissection (LND) during radical cystectomy in patients with bladder cancer (BCa). Despite the growing body of evidence of LND utility at the time of radical cystectomy (RC) in high-risk nonmuscle-invasive and muscle-invasive BCa (MIBC), therapeutic and prognostic value and optimal extent of LND remain unsolved issues. Recently published results of the first prospective, a randomized trial assessing the therapeutic benefit ...
Source
#1Moritz Maas (University of Tübingen)H-Index: 6
#2Johannes MischingerH-Index: 16
Last. Steffen Rausch (University of Tübingen)H-Index: 16
view all 9 authors...
PURPOSE The value of bladder cancer (BC) substaging into macroscopic (pT3b) and microscopic (pT3a) perivesical fat extension in lymph node (Ln)-negative patients is controversially discussed and limited evidence for prognostic relevance of additional histopathological factors in pT3 BC exists. We evaluated the prognostic value of pT3 substaging and established pathological and clinical parameters with focus on tumor invasive front (TIF) and tumor size. METHODS Specimens of 52 patients treated wi...
Source
#1Alessia Cimadamore (United Hospitals)H-Index: 17
#2Gaetano Aurilio (IEO: European Institute of Oncology)H-Index: 13
Last. Rodolfo Montironi (United Hospitals)H-Index: 96
view all 9 authors...
Current developments in the treatment of genitourinary tumors underline the unmet clinical need for biomarkers to improve decision-making in a challenging clinical setting. The detection of circulating tumor cells (CTCs) has become one of the most exciting and important new approaches to identifying biomarkers at different stages of disease in a non-invasive way. Potential applications of CTCs include monitoring treatment efficacy and early detection of progression, selecting tailored therapies,...
4 CitationsSource
#1Ho Won KangH-Index: 13
#2Wun-Jae KimH-Index: 53
Last. Seok Joong Yun (CBNU: Chungbuk National University)H-Index: 22
view all 4 authors...
Muscle-invasive bladder cancer (MIBC), a highly heterogeneous disease, shows genomic instability and a high mutation rate. Clinical outcomes are variable and responses to conventional chemotherapy differ among patients (due to inter-patient tumor heterogeneity and inter-tumor heterogeneity) and even within each individual tumor (intra-tumor heterogeneity). Emerging evidence indicates that tumor heterogeneity may play an important role in cancer progression, resistance to therapy, and metastasis....
1 CitationsSource
#1Giuseppe Palermo (CUA: The Catholic University of America)H-Index: 10
#2Pierfrancesco Bassi (CUA: The Catholic University of America)H-Index: 38
Last. Francesco Pinto (CUA: The Catholic University of America)H-Index: 21
view all 8 authors...
BACKGROUND: Circulating tumor cells (CTCs) represent a prerequisite for the formation of metastases. The aim of the study was to identify the role of CTCs as a biological marker of aggressiveness of prostate cancer and verify the expression of molecular markers predictive of response to different therapeutic approaches. METHODS: Prospective, single-arm, non-randomized trial. Twenty-four patients with prostate cancer were enrolled into two groups: group 1 (N.=11) with localized prostate cancer tr...
2 CitationsSource
#1Qi TangH-Index: 1
#2Dan YinH-Index: 1
Last. Hanmei LiH-Index: 1
view all 7 authors...
Cancer stem cells (CSCs) show self-renewal ability and multipotential differentiation like normal stem or progenitor cells, and which proliferate uncontrollably and can escape the effects of drugs and phagocytosis by immune cells. Traditional monotherapies such as surgical resection, radiotherapy and chemotherapy can't eradicate CSCs. Combination therapy may be more effective at eliminating CSCs. The present review summarizes the characteristics of CSCs and several promising combination therapie...
1 CitationsSource